Suppr超能文献

[胰腺癌联合血管切除的胰切除术的适应证与结果]

[Indication and results of pancreatectomy with combined resection of vessels for adenocarcinoma of the pancreas].

作者信息

Ogata Y, Hishinuma S, Takahashi S, Matsui J, Ozawa I

机构信息

Department of Surgery, Tochigi Cancer Center, Utsunoiya, Japan.

出版信息

Nihon Geka Gakkai Zasshi. 1997 Jul;98(7):615-21.

PMID:9276868
Abstract

Of 192 patients who received pancreatectomy for invasive adenocarcinoma of the pancreas, 107 (55. 7%) underwent combined resection of vessels at Keio University Hospital and Tochigi Cancer Center, from July 1974 until March 1996. Vascular resections included the portal and/or mesenteric vein in 103, the common hepatic artery in 14, the superior artery in 2 and the celiac axis in 5 cases. The morbidity and mortality rate are 20.2%, 1.2% in the standard resected group and 23.1%, 5.6% in the vessel resected group, respectively. Comparison of the survival rate of curability A and B patients between two groups shows no significant difference. Six patients who underwent resection of the portal and/or mesenteric vein survived more than 5 years. The longest survivor is living 13 years 6 months after surgery. Among the patients who underwent resection of the artery, two patients survived 44 and 22 months after distal pancreatectomy with resection of the celiac axis and the common hepatic artery preserving whole stomach.

摘要

1974年7月至1996年3月期间,在庆应义塾大学医院和栃木癌症中心,192例因胰腺浸润性腺癌接受胰腺切除术的患者中,107例(55.7%)接受了血管联合切除术。血管切除术包括103例门静脉和/或肠系膜静脉、14例肝总动脉、2例脾动脉和5例腹腔干。标准切除组的发病率和死亡率分别为20.2%、1.2%,血管切除组分别为23.1%、5.6%。两组间可治愈性A和B患者的生存率比较无显著差异。6例接受门静脉和/或肠系膜静脉切除术的患者存活超过5年。最长存活者术后存活13年6个月。在接受动脉切除术的患者中,2例在保留全胃的情况下,于胰体尾切除加腹腔干和肝总动脉切除术后分别存活44个月和22个月。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验